Engxenyeni enkulu yekhulu lama-20, i-cholesterol yayibhekwa njengesinye sezitha ezimbi kakhulu zomzimba onempilo. Kodwa-ke, iziphetho zezifundo ezenziwa eminyakeni yamuva zibonisa isikhathi ngasinye ukuthi lesi sici asicacile kangako. Muva nje odokotela baqala ukuhlukanisa i-cholesterol ibe "embi" futhi "enhle": eyokuqala ihlala emikhunjini yethu, eyesibili iyayikhipha bese iyihambisa esibindini, lapho i-cholesterol icutshungulwa futhi ikhishwe emzimbeni.
Namuhla kukholakala ukuthi ibhalansi yalezi zinhlobo ezimbili ezibalulekile, futhi amazinga aphansi e-cholesterol - ngokuphambene nalokho, akude nenkomba engcono kakhulu, ngoba iyadingeka ukuze kuhlanganiswe amahomoni athile, kanye ne-vitamin D.… Ukungabaza kanye nokwenqaba ukudla okunamafutha ukwehlisa izinga lale nto.
Iqiniso yilokho cishe ama-80% e-cholesterol equkethwe emzimbeni akhiqizwa isibindi, futhi sithola kuphela ama-20% asele ekudleni.... Ngakho-ke, ngokuncipha kwezinga le-cholesterol evela "ngaphandle", umzimba wethu uzozama ukunxephezela ukuntuleka kwayo, okungase, ngokuphambene nalokho, kuholele ekwandeni kokuqukethwe kwalesi sici egazini.
Ngokusho kwenhloko yocwaningo, u-Albert Salehi, i-receptor itholakala kumanyikwe I-GPR183, okwenziwa kusebenze ngokuthinta omunye wemikhiqizo ye-cholesterol ekhiqizwa isibindi. Lokhu kutholakala kungase kuvumele ukuthuthukiswa kwendlela yokuvimbela ukubopha kwalesi receptor ku-cholesterol, noma, ngokuphambene, kusebenze. Kungaba njalo ilusizo kubantu abanamazinga aphansi e-cholesterol, ngenxa yokukhiqizwa kwe-insulin eyanele, futhi ngokuphambene nalokho - ukunciphisa inani layo emzimbeni.... Phela, izinga elikhulayo le-insulin lingathinta ukwanda kwesifiso sokudla futhi, ngokufanele, nesisindo. Ingasaphathwa ingozi yesifo sikashukela.